HAE logo

Haemonetics (HAE) EBITDA

Annual EBITDA

$262.10 M
+$12.76 M+5.12%

31 March 2024

HAE EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBITDA

$80.91 M
+$12.02 M+17.45%

28 September 2024

HAE Quarterly EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBITDA

$276.90 M
+$22.60 M+8.89%

28 September 2024

HAE TTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HAE EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.1%+38.8%+6.1%
3 y3 years+50.6%+34.8%+104.8%
5 y5 years+35.8%+5.4%+37.9%

HAE EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+50.6%at high+83.8%at high+104.8%
5 y5 yearsat high+50.6%at high>+9999.0%at high+104.8%
alltimeall timeat high+610.3%at high+310.4%at high+696.3%

Haemonetics EBITDA History

DateAnnualQuarterlyTTM
Sept 2024
-
$80.91 M(+17.5%)
$276.90 M(+8.9%)
June 2024
-
$68.89 M(+19.6%)
$254.30 M(-3.0%)
Mar 2024
$262.10 M(+5.1%)
-
-
Mar 2024
-
$57.58 M(-17.2%)
$262.10 M(-0.6%)
Dec 2023
-
$69.51 M(+19.2%)
$263.63 M(+1.0%)
Sept 2023
-
$58.32 M(-24.0%)
$260.96 M(-4.3%)
June 2023
-
$76.69 M(+29.7%)
$272.82 M(+9.4%)
Mar 2023
$249.34 M(+39.7%)
$59.11 M(-11.6%)
$249.34 M(+6.4%)
Dec 2022
-
$66.85 M(-4.7%)
$234.24 M(+3.0%)
Sept 2022
-
$70.17 M(+31.9%)
$227.41 M(+10.8%)
June 2022
-
$53.21 M(+20.9%)
$205.29 M(+15.0%)
Mar 2022
$178.50 M(+2.6%)
$44.01 M(-26.7%)
$178.50 M(+32.0%)
Dec 2021
-
$60.02 M(+24.9%)
$135.22 M(-0.9%)
Sept 2021
-
$48.04 M(+81.8%)
$136.40 M(-18.8%)
June 2021
-
$26.42 M(+3495.0%)
$168.02 M(-3.5%)
Mar 2021
$174.03 M(-18.5%)
$735.00 K(-98.8%)
$174.03 M(-23.7%)
Dec 2020
-
$61.20 M(-23.2%)
$228.07 M(-2.9%)
Sept 2020
-
$79.66 M(+145.6%)
$234.83 M(+1.2%)
June 2020
-
$32.44 M(-40.8%)
$231.94 M(+8.6%)
Mar 2020
$213.64 M(+10.7%)
$54.77 M(-19.4%)
$213.64 M(+0.5%)
Dec 2019
-
$67.96 M(-11.5%)
$212.50 M(+5.8%)
Sept 2019
-
$76.77 M(+443.1%)
$200.81 M(+14.5%)
June 2019
-
$14.13 M(-73.6%)
$175.39 M(-9.1%)
Mar 2019
$192.96 M(+25.8%)
$53.64 M(-4.7%)
$192.96 M(+9.3%)
Dec 2018
-
$56.27 M(+9.6%)
$176.58 M(+23.0%)
Sept 2018
-
$51.35 M(+62.0%)
$143.61 M(+3.5%)
June 2018
-
$31.71 M(-14.9%)
$138.71 M(-9.6%)
Mar 2018
$153.40 M(+118.1%)
$37.26 M(+59.9%)
$153.40 M(+89.8%)
Dec 2017
-
$23.29 M(-49.9%)
$80.84 M(-20.0%)
Sept 2017
-
$46.45 M(+0.1%)
$101.04 M(-1.0%)
June 2017
-
$46.40 M(-231.4%)
$102.09 M(+45.1%)
Mar 2017
$70.35 M(+53.0%)
-$35.30 M(-181.2%)
$70.35 M(-42.5%)
Dec 2016
-
$43.49 M(-8.4%)
$122.30 M(+203.1%)
Sept 2016
-
$47.50 M(+224.0%)
$40.35 M(+16.1%)
June 2016
-
$14.66 M(-11.9%)
$34.77 M(-24.4%)
Mar 2016
$45.97 M(-64.4%)
$16.64 M(-143.3%)
$45.97 M(-29.9%)
Dec 2015
-
-$38.45 M(-191.7%)
$65.55 M(-54.6%)
Sept 2015
-
$41.92 M(+62.1%)
$144.53 M(+6.2%)
June 2015
-
$25.86 M(-28.6%)
$136.13 M(+5.4%)
Mar 2015
$129.12 M(-0.6%)
$36.22 M(-10.6%)
$129.12 M(+0.0%)
Dec 2014
-
$40.53 M(+20.9%)
$129.08 M(+1.5%)
Sept 2014
-
$33.52 M(+77.9%)
$127.22 M(-7.2%)
June 2014
-
$18.84 M(-47.9%)
$137.03 M(+5.5%)
Mar 2014
$129.93 M(+3.0%)
$36.18 M(-6.4%)
$129.93 M(-3.4%)
Dec 2013
-
$38.67 M(-10.8%)
$134.44 M(+3.7%)
Sept 2013
-
$43.33 M(+268.8%)
$129.65 M(+14.1%)
June 2013
-
$11.75 M(-71.1%)
$113.65 M(-9.9%)
Mar 2013
$126.17 M(-8.0%)
$40.70 M(+20.1%)
$126.16 M(+5.9%)
Dec 2012
-
$33.88 M(+24.0%)
$119.14 M(-3.3%)
Sept 2012
-
$27.33 M(+12.7%)
$123.22 M(-3.0%)
June 2012
-
$24.26 M(-28.0%)
$127.09 M(-8.4%)
Mar 2012
$137.14 M(-12.5%)
$33.67 M(-11.3%)
$138.72 M(-3.1%)
Dec 2011
-
$37.96 M(+21.7%)
$143.17 M(-2.0%)
Sept 2011
-
$31.20 M(-13.1%)
$146.11 M(-6.4%)
June 2011
-
$35.90 M(-5.8%)
$156.10 M(-0.7%)
Mar 2011
$156.80 M(+25.2%)
$38.12 M(-6.8%)
$157.14 M(+16.9%)
Dec 2010
-
$40.89 M(-0.7%)
$134.38 M(+3.2%)
Sept 2010
-
$41.19 M(+11.5%)
$130.19 M(+3.3%)
June 2010
-
$36.94 M(+140.4%)
$125.97 M(+0.6%)
Mar 2010
$125.25 M(+3.1%)
$15.36 M(-58.1%)
$125.24 M(-7.1%)
Dec 2009
-
$36.71 M(-0.7%)
$134.88 M(+1.1%)
Sept 2009
-
$36.97 M(+2.1%)
$133.44 M(+2.5%)
June 2009
-
$36.21 M(+44.9%)
$130.18 M(+7.3%)
Mar 2009
$121.53 M(+19.8%)
$25.00 M(-29.1%)
$121.29 M(-3.3%)
Dec 2008
-
$35.27 M(+4.6%)
$125.39 M(+6.8%)
Sept 2008
-
$33.71 M(+23.4%)
$117.43 M(+10.9%)
June 2008
-
$27.32 M(-6.1%)
$105.85 M(+4.3%)
Mar 2008
$101.48 M
$29.10 M(+6.5%)
$101.49 M(-2.7%)
Dec 2007
-
$27.31 M(+23.5%)
$104.34 M(+3.4%)
DateAnnualQuarterlyTTM
Sept 2007
-
$22.12 M(-3.6%)
$100.94 M(+0.4%)
June 2007
-
$22.96 M(-28.1%)
$100.50 M(+1.0%)
Mar 2007
$99.32 M(-20.0%)
$31.95 M(+33.6%)
$99.47 M(+1.5%)
Dec 2006
-
$23.91 M(+10.3%)
$98.03 M(-19.4%)
Sept 2006
-
$21.68 M(-1.2%)
$121.63 M(-0.5%)
June 2006
-
$21.94 M(-28.1%)
$122.28 M(-1.5%)
Mar 2006
$124.17 M(+41.9%)
$30.50 M(-35.8%)
$124.17 M(+6.8%)
Dec 2005
-
$47.51 M(+112.7%)
$116.29 M(+28.5%)
Sept 2005
-
$22.33 M(-6.3%)
$90.48 M(+1.4%)
June 2005
-
$23.83 M(+5.3%)
$89.22 M(+1.9%)
Mar 2005
$87.52 M(+13.0%)
$22.62 M(+4.3%)
$87.52 M(-0.5%)
Dec 2004
-
$21.70 M(+2.9%)
$87.96 M(+0.0%)
Sept 2004
-
$21.08 M(-4.7%)
$87.95 M(+4.7%)
June 2004
-
$22.12 M(-4.1%)
$84.02 M(+8.2%)
Mar 2004
$77.44 M(+17.5%)
$23.06 M(+6.4%)
$77.67 M(+15.9%)
Dec 2003
-
$21.68 M(+26.4%)
$67.01 M(+3.0%)
Sept 2003
-
$17.15 M(+8.8%)
$65.06 M(+0.2%)
June 2003
-
$15.77 M(+27.2%)
$64.92 M(-1.5%)
Mar 2003
$65.91 M(-8.5%)
$12.40 M(-37.2%)
$65.91 M(-18.7%)
Dec 2002
-
$19.74 M(+16.0%)
$81.06 M(+19.4%)
Sept 2002
-
$17.02 M(+1.5%)
$67.86 M(-7.6%)
June 2002
-
$16.76 M(-39.2%)
$73.45 M(-17.8%)
Mar 2002
$72.06 M(-11.1%)
$27.55 M(+320.9%)
$89.30 M(-8.1%)
Dec 2001
-
$6.54 M(-71.0%)
$97.13 M(-9.7%)
Sept 2001
-
$22.60 M(-30.7%)
$107.59 M(+8.4%)
June 2001
-
$32.61 M(-7.8%)
$99.21 M(+22.6%)
Mar 2001
$81.02 M(+10.8%)
$35.37 M(+108.1%)
$80.92 M(+11.7%)
Dec 2000
-
$17.00 M(+19.5%)
$72.47 M(+3.9%)
Sept 2000
-
$14.23 M(-0.6%)
$69.77 M(-2.6%)
June 2000
-
$14.31 M(-46.8%)
$71.64 M(-2.2%)
Mar 2000
$73.13 M(-9.5%)
$26.93 M(+88.3%)
$73.23 M(-12.9%)
Dec 1999
-
$14.30 M(-11.2%)
$84.06 M(-0.1%)
Sept 1999
-
$16.10 M(+1.3%)
$84.16 M(-1.3%)
June 1999
-
$15.90 M(-57.9%)
$85.26 M(+4.3%)
Mar 1999
$80.76 M(+49.8%)
$37.76 M(+162.2%)
$81.76 M(+59.1%)
Dec 1998
-
$14.40 M(-16.3%)
$51.40 M(-0.4%)
Sept 1998
-
$17.20 M(+38.7%)
$51.60 M(+4.2%)
June 1998
-
$12.40 M(+67.6%)
$49.50 M(-4.8%)
Mar 1998
$53.90 M(-25.1%)
$7.40 M(-49.3%)
$52.00 M(-24.4%)
Dec 1997
-
$14.60 M(-3.3%)
$68.80 M(+0.1%)
Sept 1997
-
$15.10 M(+1.3%)
$68.70 M(-2.1%)
June 1997
-
$14.90 M(-38.4%)
$70.20 M(-3.4%)
Mar 1997
$72.00 M(+6.8%)
$24.20 M(+66.9%)
$72.70 M(+16.9%)
Dec 1996
-
$14.50 M(-12.7%)
$62.20 M(-5.5%)
Sept 1996
-
$16.60 M(-4.6%)
$65.80 M(-1.9%)
June 1996
-
$17.40 M(+27.0%)
$67.10 M(-0.4%)
Mar 1996
$67.40 M(+2.0%)
$13.70 M(-24.3%)
$67.40 M(-3.2%)
Dec 1995
-
$18.10 M(+1.1%)
$69.60 M(+2.1%)
Sept 1995
-
$17.90 M(+1.1%)
$68.20 M(+0.7%)
June 1995
-
$17.70 M(+11.3%)
$67.70 M(+2.1%)
Mar 1995
$66.10 M(+5.8%)
$15.90 M(-4.8%)
$66.30 M(-0.5%)
Dec 1994
-
$16.70 M(-4.0%)
$66.60 M(+0.3%)
Sept 1994
-
$17.40 M(+6.7%)
$66.40 M(+2.0%)
June 1994
-
$16.30 M(+0.6%)
$65.10 M(+4.0%)
Mar 1994
$62.50 M(+24.3%)
$16.20 M(-1.8%)
$62.60 M(+4.7%)
Dec 1993
-
$16.50 M(+2.5%)
$59.80 M(+5.1%)
Sept 1993
-
$16.10 M(+16.7%)
$56.90 M(+6.8%)
June 1993
-
$13.80 M(+3.0%)
$53.30 M(+5.5%)
Mar 1993
$50.30 M(+36.3%)
$13.40 M(-1.5%)
$50.50 M(+6.1%)
Dec 1992
-
$13.60 M(+8.8%)
$47.60 M(+9.2%)
Sept 1992
-
$12.50 M(+13.6%)
$43.60 M(+9.0%)
June 1992
-
$11.00 M(+4.8%)
$40.00 M(+8.7%)
Mar 1992
$36.90 M(-76.5%)
$10.50 M(+9.4%)
$36.80 M(-44.0%)
Dec 1991
-
$9.60 M(+7.9%)
$65.70 M(-31.1%)
Sept 1991
-
$8.90 M(+14.1%)
$95.40 M(-24.2%)
June 1991
-
$7.80 M(-80.2%)
$125.80 M(-20.0%)
Mar 1991
$157.30 M
$39.40 M(+0.3%)
$157.30 M(+33.4%)
Dec 1990
-
$39.30 M(0.0%)
$117.90 M(+50.0%)
Sept 1990
-
$39.30 M(0.0%)
$78.60 M(+100.0%)
June 1990
-
$39.30 M
$39.30 M

FAQ

  • What is Haemonetics annual earnings before interest, taxes, depreciation & amortization?
  • What is the all time high annual EBITDA for Haemonetics?
  • What is Haemonetics annual EBITDA year-on-year change?
  • What is Haemonetics quarterly earnings before interest, taxes, depreciation & amortization?
  • What is the all time high quarterly EBITDA for Haemonetics?
  • What is Haemonetics quarterly EBITDA year-on-year change?
  • What is Haemonetics TTM earnings before interest, taxes, depreciation & amortization?
  • What is the all time high TTM EBITDA for Haemonetics?
  • What is Haemonetics TTM EBITDA year-on-year change?

What is Haemonetics annual earnings before interest, taxes, depreciation & amortization?

The current annual EBITDA of HAE is $262.10 M

What is the all time high annual EBITDA for Haemonetics?

Haemonetics all-time high annual earnings before interest, taxes, depreciation & amortization is $262.10 M

What is Haemonetics annual EBITDA year-on-year change?

Over the past year, HAE annual earnings before interest, taxes, depreciation & amortization has changed by +$12.76 M (+5.12%)

What is Haemonetics quarterly earnings before interest, taxes, depreciation & amortization?

The current quarterly EBITDA of HAE is $80.91 M

What is the all time high quarterly EBITDA for Haemonetics?

Haemonetics all-time high quarterly earnings before interest, taxes, depreciation & amortization is $80.91 M

What is Haemonetics quarterly EBITDA year-on-year change?

Over the past year, HAE quarterly earnings before interest, taxes, depreciation & amortization has changed by +$22.60 M (+38.75%)

What is Haemonetics TTM earnings before interest, taxes, depreciation & amortization?

The current TTM EBITDA of HAE is $276.90 M

What is the all time high TTM EBITDA for Haemonetics?

Haemonetics all-time high TTM earnings before interest, taxes, depreciation & amortization is $276.90 M

What is Haemonetics TTM EBITDA year-on-year change?

Over the past year, HAE TTM earnings before interest, taxes, depreciation & amortization has changed by +$15.93 M (+6.11%)